Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Patent
1989-02-22
1990-11-27
Lee, Mary C.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
548317, 548320, 548321, 548322, A61K 31415, C07D23330
Patent
active
049735985
ABSTRACT:
HMG-CoA reductase-inhibiting compounds of the formula ##STR1## in which R.sup.1 is an optionally substituted alkyl as cycloalkyl radical,
REFERENCES:
patent: 2514380 (1950-07-01), Duschinsky
patent: 2602798 (1952-07-01), Hoefle et al.
patent: 3021338 (1962-02-01), Bortnick
patent: 3184460 (1965-05-01), Akkermann et al.
patent: 3234000 (1966-02-01), Bartels et al.
patent: 3641049 (1972-02-01), Sandstrom et al.
patent: 3728355 (1973-04-01), D'Amico et al.
patent: 4011238 (1977-03-01), Fontanella et al.
patent: 4188397 (1980-02-01), Hill
patent: 4315022 (1982-02-01), Wootton et al.
Angerbauer Rolf
Bischoff Hilmar
Fey Peter
Hubsch Walter
Petzinna Dieter
Bayer Aktiengesellschaft
Lee Mary C.
Scalzo Catherine
LandOfFree
Substituted imidazolinones and imidazolinethiones does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Substituted imidazolinones and imidazolinethiones, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Substituted imidazolinones and imidazolinethiones will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1032059